Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions |
| October 22, 2015 | October 2015 Bond Updates |
|
Valeant calls short seller reports alleging sham transactions erroneous. |
| View more at: http://www.forbes.com/sites/antoinegara/2015/10/21/valeant-pharmaceuticals-rebuts-short-seller-claims-of-enron-like-sham-transactions/ |
| Related News |
|